SyInfect (Syntrion GmbH)
Welcome to the PulseAid listing for the SyInfect drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Syntrion GmbH |
| NON-PROPRIETARY NAME: | PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM and PENICILLIUM GLABRUM |
| SUBSTANCE NAME: | PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-02-15 |
| END MARKETING DATE: | 2019-11-30 |
SyInfect HUMAN OTC DRUG Details:
| Item Description | SyInfect from Syntrion GmbH |
| LABELER NAME: | Syntrion GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125; 125(mg/1; mg/1) |
| START MARKETING DATE: | 2015-02-15 |
| END MARKETING DATE: | 2019-11-30 |
| PRODUCT ID: | 10424-108_267c52af-4ce8-4bfa-9d16-ff5122ae5e4f |
| PRODUCT NDC: | 10424-108 |
| APPLICATION NUMBER: | |
Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:
